NexImmune Inc (NEXI)
3.37
-0.04
(-1.17%)
USD |
NASDAQ |
Apr 26, 16:00
3.42
+0.05
(+1.48%)
After-Hours: 20:00
NexImmune Enterprise Value: -0.0259M for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | -0.0259M |
| April 25, 2024 | 0.029M |
| April 24, 2024 | -0.1767M |
| April 23, 2024 | 0.0564M |
| April 22, 2024 | 0.3512M |
| April 19, 2024 | 0.1386M |
| April 18, 2024 | -0.1219M |
| April 17, 2024 | -0.3275M |
| April 16, 2024 | 0.1112M |
| April 15, 2024 | 0.2209M |
| April 12, 2024 | 0.3032M |
| April 11, 2024 | 0.7556M |
| April 10, 2024 | 0.7762M |
| April 09, 2024 | 0.3169M |
| April 08, 2024 | 1.249M |
| April 05, 2024 | 0.4403M |
| April 04, 2024 | 1.633M |
| April 03, 2024 | 2.278M |
| April 02, 2024 | 2.703M |
| April 01, 2024 | 3.004M |
| March 28, 2024 | 3.045M |
| March 27, 2024 | 2.908M |
| March 26, 2024 | 3.155M |
| March 25, 2024 | 3.237M |
| March 22, 2024 | 3.086M |
| Date | Value |
|---|---|
| March 21, 2024 | 3.402M |
| March 20, 2024 | 3.196M |
| March 19, 2024 | 3.251M |
| March 18, 2024 | 3.032M |
| March 15, 2024 | 3.292M |
| March 14, 2024 | 3.649M |
| March 13, 2024 | 3.704M |
| March 12, 2024 | 3.416M |
| March 11, 2024 | 3.525M |
| March 08, 2024 | 3.580M |
| March 07, 2024 | 3.991M |
| March 06, 2024 | 4.307M |
| March 05, 2024 | 4.266M |
| March 04, 2024 | 3.539M |
| March 01, 2024 | 3.841M |
| February 29, 2024 | 4.080M |
| February 28, 2024 | 4.184M |
| February 27, 2024 | 4.458M |
| February 26, 2024 | 4.575M |
| February 23, 2024 | 4.158M |
| February 22, 2024 | 4.706M |
| February 21, 2024 | 5.591M |
| February 20, 2024 | 6.503M |
| February 16, 2024 | 5.487M |
| February 15, 2024 | 6.347M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-40.93M
Minimum
Mar 11 2022
651.27M
Maximum
Feb 26 2021
62.00M
Average
-6.796M
Median
Enterprise Value Benchmarks
| Revelation Biosciences Inc | -8.432M |
| Spectral AI Inc | 23.36M |
| Corbus Pharmaceuticals Holdings Inc | 355.17M |
| Processa Pharmaceuticals Inc | 1.434M |
| Ensysce Biosciences Inc | 3.684M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.359M |
| Total Expenses (Quarterly) | 4.677M |
| EPS Diluted (Quarterly) | -4.99 |
| Earnings Yield | -916.6% |